4. Health-related quality of life in transplant noneligible newly diagnosed multiple myeloma patients treated with melphalan/prednisolone plus either thalidomide or lenalidomide; results of the HOVON87/NMSG18 study

Kongsgaard Nielsen, L. (Oplægsholder), Abildgaard , N. (Andet)

Aktivitet: Foredrag og mundtlige bidragKonferenceoplæg

Periode8. sep. 2017
BegivenhedstitelNordic Myeloma Study Group Plenary Meeting
BegivenhedstypeSeminar
PlaceringTrondheim, Norge